Logo image of 6D81.DE

DUPONT DE NEMOURS INC (6D81.DE) Stock Fundamental Analysis

FRA:6D81 - Deutsche Boerse Ag - US26614N1028 - Common Stock - Currency: EUR

74.13  +0.07 (+0.09%)

Fundamental Rating

5

6D81 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Chemicals industry. 6D81 has an average financial health and profitability rating. 6D81 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

6D81 had positive earnings in the past year.
In the past year 6D81 had a positive cash flow from operations.
Of the past 5 years 6D81 4 years were profitable.
Each year in the past 5 years 6D81 had a positive operating cash flow.
6D81.DE Yearly Net Income VS EBIT VS OCF VS FCF6D81.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B 10B

1.2 Ratios

With a Return On Assets value of 2.13%, 6D81 perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
Looking at the Return On Equity, with a value of 3.30%, 6D81 is in line with its industry, outperforming 54.39% of the companies in the same industry.
With a Return On Invested Capital value of 3.80%, 6D81 perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 6D81 is below the industry average of 6.58%.
The 3 year average ROIC (3.62%) for 6D81 is below the current ROIC(3.80%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.13%
ROE 3.3%
ROIC 3.8%
ROA(3y)9.81%
ROA(5y)5.2%
ROE(3y)16.1%
ROE(5y)8.37%
ROIC(3y)3.62%
ROIC(5y)3%
6D81.DE Yearly ROA, ROE, ROIC6D81.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

1.3 Margins

Looking at the Profit Margin, with a value of 6.55%, 6D81 is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
6D81's Profit Margin has declined in the last couple of years.
6D81 has a Operating Margin of 14.71%. This is amongst the best in the industry. 6D81 outperforms 85.96% of its industry peers.
6D81's Operating Margin has improved in the last couple of years.
The Gross Margin of 6D81 (36.40%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of 6D81 has grown nicely.
Industry RankSector Rank
OM 14.71%
PM (TTM) 6.55%
GM 36.4%
OM growth 3Y2.24%
OM growth 5Y7.68%
PM growth 3YN/A
PM growth 5Y-27.03%
GM growth 3Y-1.34%
GM growth 5Y1.68%
6D81.DE Yearly Profit, Operating, Gross Margins6D81.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

5

2. Health

2.1 Basic Checks

6D81 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 6D81 has been reduced compared to 1 year ago.
The number of shares outstanding for 6D81 has been reduced compared to 5 years ago.
Compared to 1 year ago, 6D81 has a worse debt to assets ratio.
6D81.DE Yearly Shares Outstanding6D81.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
6D81.DE Yearly Total Debt VS Total Assets6D81.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that 6D81 is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.19, 6D81 is not doing good in the industry: 71.93% of the companies in the same industry are doing better.
The Debt to FCF ratio of 6D81 is 5.63, which is a neutral value as it means it would take 6D81, 5.63 years of fcf income to pay off all of its debts.
6D81 has a Debt to FCF ratio of 5.63. This is in the better half of the industry: 6D81 outperforms 73.68% of its industry peers.
6D81 has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.30, 6D81 is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 5.63
Altman-Z 1.19
ROIC/WACC0.43
WACC8.8%
6D81.DE Yearly LT Debt VS Equity VS FCF6D81.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 2.28 indicates that 6D81 has no problem at all paying its short term obligations.
6D81 has a better Current ratio (2.28) than 68.42% of its industry peers.
6D81 has a Quick Ratio of 1.49. This is a normal value and indicates that 6D81 is financially healthy and should not expect problems in meeting its short term obligations.
6D81's Quick ratio of 1.49 is fine compared to the rest of the industry. 6D81 outperforms 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 1.49
6D81.DE Yearly Current Assets VS Current Liabilites6D81.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.86% over the past year.
The earnings per share for 6D81 have been decreasing by -22.35% on average. This is quite bad
Looking at the last year, 6D81 shows a decrease in Revenue. The Revenue has decreased by -0.67% in the last year.
6D81 shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.79% yearly.
EPS 1Y (TTM)8.86%
EPS 3Y1.08%
EPS 5Y-22.35%
EPS Q2Q%28.26%
Revenue 1Y (TTM)-0.67%
Revenue growth 3Y2.74%
Revenue growth 5Y-11.79%
Sales Q2Q%4.38%

3.2 Future

Based on estimates for the next years, 6D81 will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.79% on average per year.
Based on estimates for the next years, 6D81 will show a small growth in Revenue. The Revenue will grow by 5.25% on average per year.
EPS Next Y15.78%
EPS Next 2Y13.48%
EPS Next 3Y13.11%
EPS Next 5Y9.79%
Revenue Next Year2.23%
Revenue Next 2Y3.41%
Revenue Next 3Y4%
Revenue Next 5Y5.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
6D81.DE Yearly Revenue VS Estimates6D81.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
6D81.DE Yearly EPS VS Estimates6D81.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.09, 6D81 is valued on the expensive side.
Based on the Price/Earnings ratio, 6D81 is valued a bit cheaper than the industry average as 70.18% of the companies are valued more expensively.
6D81 is valuated rather cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
6D81 is valuated rather expensively with a Price/Forward Earnings ratio of 17.09.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 6D81 is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 92.74. 6D81 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 20.09
Fwd PE 17.09
6D81.DE Price Earnings VS Forward Price Earnings6D81.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

6D81's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as 6D81.
Industry RankSector Rank
P/FCF 25.13
EV/EBITDA 12.59
6D81.DE Per share data6D81.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

6D81's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
6D81 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 6D81's earnings are expected to grow with 13.11% in the coming years.
PEG (NY)1.27
PEG (5Y)N/A
EPS Next 2Y13.48%
EPS Next 3Y13.11%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.98%, 6D81 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.94, 6D81 has a dividend in line with its industry peers.
6D81's Dividend Yield is comparable with the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

The dividend of 6D81 decreases each year by -20.30%.
Dividend Growth(5Y)-20.3%
Div Incr Years4
Div Non Decr Years4
6D81.DE Yearly Dividends per share6D81.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

6D81 pays out 79.10% of its income as dividend. This is not a sustainable payout ratio.
DP79.1%
EPS Next 2Y13.48%
EPS Next 3Y13.11%
6D81.DE Yearly Income VS Free CF VS Dividend6D81.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B
6D81.DE Dividend Payout.6D81.DE Dividend Payout, showing the Payout Ratio.6D81.DE Dividend Payout.PayoutRetained Earnings

DUPONT DE NEMOURS INC

FRA:6D81 (2/4/2025, 7:00:00 PM)

74.13

+0.07 (+0.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-11 2025-02-11/amc
Inst Owners72.37%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap30.98B
Analysts77.04
Price Target94.09 (26.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend1.47
Dividend Growth(5Y)-20.3%
DP79.1%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.94%
Min EPS beat(2)10.57%
Max EPS beat(2)11.31%
EPS beat(4)3
Avg EPS beat(4)9.98%
Min EPS beat(4)-0.58%
Max EPS beat(4)18.61%
EPS beat(8)6
Avg EPS beat(8)7.25%
EPS beat(12)10
Avg EPS beat(12)8.18%
EPS beat(16)14
Avg EPS beat(16)7.87%
Revenue beat(2)1
Avg Revenue beat(2)-1.16%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)0.96%
Revenue beat(4)2
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-3.94%
Max Revenue beat(4)1.17%
Revenue beat(8)2
Avg Revenue beat(8)-1.8%
Revenue beat(12)3
Avg Revenue beat(12)-3.09%
Revenue beat(16)3
Avg Revenue beat(16)-12.53%
PT rev (1m)-3.45%
PT rev (3m)4.02%
EPS NQ rev (1m)-0.66%
EPS NQ rev (3m)-3.07%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)3.8%
Revenue NQ rev (1m)-0.57%
Revenue NQ rev (3m)-0.53%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 20.09
Fwd PE 17.09
P/S 2.63
P/FCF 25.13
P/OCF 17.43
P/B 1.32
P/tB 18.14
EV/EBITDA 12.59
EPS(TTM)3.69
EY4.98%
EPS(NY)4.34
Fwd EY5.85%
FCF(TTM)2.95
FCFY3.98%
OCF(TTM)4.25
OCFY5.74%
SpS28.22
BVpS56.05
TBVpS4.09
PEG (NY)1.27
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.13%
ROE 3.3%
ROCE 5.18%
ROIC 3.8%
ROICexc 3.98%
ROICexgc 12.47%
OM 14.71%
PM (TTM) 6.55%
GM 36.4%
FCFM 10.45%
ROA(3y)9.81%
ROA(5y)5.2%
ROE(3y)16.1%
ROE(5y)8.37%
ROIC(3y)3.62%
ROIC(5y)3%
ROICexc(3y)3.97%
ROICexc(5y)3.23%
ROICexgc(3y)11.63%
ROICexgc(5y)9.67%
ROCE(3y)4.95%
ROCE(5y)4.11%
ROICexcg growth 3Y47.86%
ROICexcg growth 5Y33.08%
ROICexc growth 3Y25.31%
ROICexc growth 5Y19.91%
OM growth 3Y2.24%
OM growth 5Y7.68%
PM growth 3YN/A
PM growth 5Y-27.03%
GM growth 3Y-1.34%
GM growth 5Y1.68%
F-Score8
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 5.63
Debt/EBITDA 2.4
Cap/Depr 47.35%
Cap/Sales 4.62%
Interest Coverage 250
Cash Conversion 61.58%
Profit Quality 159.45%
Current Ratio 2.28
Quick Ratio 1.49
Altman-Z 1.19
F-Score8
WACC8.8%
ROIC/WACC0.43
Cap/Depr(3y)59.35%
Cap/Depr(5y)58.8%
Cap/Sales(3y)5.98%
Cap/Sales(5y)8.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.86%
EPS 3Y1.08%
EPS 5Y-22.35%
EPS Q2Q%28.26%
EPS Next Y15.78%
EPS Next 2Y13.48%
EPS Next 3Y13.11%
EPS Next 5Y9.79%
Revenue 1Y (TTM)-0.67%
Revenue growth 3Y2.74%
Revenue growth 5Y-11.79%
Sales Q2Q%4.38%
Revenue Next Year2.23%
Revenue Next 2Y3.41%
Revenue Next 3Y4%
Revenue Next 5Y5.25%
EBIT growth 1Y0.28%
EBIT growth 3Y5.04%
EBIT growth 5Y-5.01%
EBIT Next Year36.26%
EBIT Next 3Y16.99%
EBIT Next 5Y13.62%
FCF growth 1Y114.84%
FCF growth 3Y-23.5%
FCF growth 5Y8.4%
OCF growth 1Y37.6%
OCF growth 3Y-22.34%
OCF growth 5Y-16.52%